An increasing number of mutations at core spliceosome components, such as S3FB1 and U2AF1, or upregulation of specific splicing factors, such as SRSF1 and other members of the SR protein family, which are now considered oncogenes, have been intimately linked to tumour progression and malignancy [64]. The gene discussed is SRSF1; the disease is neoplasm.